Bob Rosenthal

Insider Reports History

Location
Boston, MA
Signature
/s/ Michael Simone, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Bob Rosenthal:

Company Role Class Num Shares Value Price $ Report Date Ownership
BRUKER CORP Director Common Stock 38,781 $1,878,551 $48.44 15 Feb 2026 Direct
SAFEGUARD SCIENTIFICS INC Director Common Stock 81,855 $84,466 $1.03 15 Apr 2022 Direct
INVIVO THERAPEUTICS HOLDINGS CORP. Director Stock Option (right to buy) 4,200 17 Nov 2022 Direct

Insider Reports Filed by Bob Rosenthal

Symbol Company Period Transactions Value $ Form Type Role Filing Time
BRKR BRUKER CORP 15 Feb 2026 1 $0 4 Director 18 Feb 2026, 16:15
BRKR BRUKER CORP 15 Feb 2025 1 $0 4 Director 19 Feb 2025, 16:38
BRKR BRUKER CORP 15 Aug 2024 5 -$3,673 4 Director 16 Aug 2024, 16:39
BRKR BRUKER CORP 05 Jan 2024 1 $0 4 Director 09 Jan 2024, 16:05
BRKR BRUKER CORP 05 Jan 2023 1 $0 4 Director 09 Jan 2023, 15:24
/report/000110465922120829-rosenthal-bob-2022-11-17 INVIVO THERAPEUTICS HOLDINGS CORP. 17 Nov 2022 1 $0 4 Director 21 Nov 2022, 16:04
SFES SAFEGUARD SCIENTIFICS INC 15 Apr 2022 1 +$26,649 4 Director 18 Apr 2022, 07:29
SFES SAFEGUARD SCIENTIFICS INC 17 Jan 2022 1 +$27,782 4 Director 18 Jan 2022, 07:54
BRKR BRUKER CORP 05 Jan 2022 1 $0 4 Director 06 Jan 2022, 15:10
SFES SAFEGUARD SCIENTIFICS INC 15 Oct 2021 1 +$26,859 4 Director 18 Oct 2021, 09:28
SFES SAFEGUARD SCIENTIFICS INC 15 Jul 2021 1 +$30,243 4 Director 16 Jul 2021, 09:33
SFES SAFEGUARD SCIENTIFICS INC 30 Jun 2021 1 $0 4 Director 30 Jun 2021, 12:29
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .